Deletion of the N-terminus of murine map2 by gene targeting disrupts hippocampal ca1 neuron architecture and alters contextual memory.
Microtubule-associated protein-2 (MAP2) is a brain specific A-kinase anchoring protein that targets the cyclic AMP-dependent protein kinase holoenzyme (PKA) to microtubules. Phosphorylation of MAP2 by different protein kinases is crucial for neuronal growth. The N-terminus of MAP2 contains the binding site for regulatory subunit II of cAMP-dependent protein kinase (PKA-RIIbeta). Using homologous recombination, we created a mutant line of mice (delta1-158) that express truncated MAP2 lacking the N-terminal peptide and the PKA binding site. Deletion of the PKA binding site from the MAP2 gene resulted in decreased efficiency of MAP2 phosphorylation. Biochemical and immunohistochemical studies demonstrate major changes in the morphology of hippocampal neurons in delta1-158 mice. Behavioral tests indicate that delta1-158 mice were impaired (exhibited less conditioned freezing) relative to Wild-Type (WT) controls during a test of contextual, but not during auditory cue, fear conditioning when tested at 8 weeks or 8 months of age. The delta1-158 mice displayed a heightened sensitivity to shock at 8 weeks, but not at 8 months of age. We conclude that PKA binding to MAP2 and MAP2 phosphorylation is essential for the selective development of contextual memory.
Khuchua
Z
Z
Vanderbilt University Medical Center, Department of Pediatrics, B3307 MCN, 1161 21 Avenue South, Nashville, TN 37232, USA. zaza.khuchua@vanderbilt.edu
Wozniak
D F
DF
Bardgett
M E
ME
Yue
Z
Z
McDonald
M
M
Boero
J
J
Hartman
R E
RE
Sims
H
H
Strauss
A W
AW
D000161:Acoustic Stimulation; D000255:Adenosine Triphosphate / Q000378:metabolism; D000595:Amino Acid Sequence; D020533:Angiogenesis Inhibitors / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal; D015153:Blotting, Western; D003213:Conditioning, Psychological; D003463:Cues; D000242:Cyclic AMP / Q000494:pharmacology; D004558:Electric Stimulation / Q000009:adverse effects; D005239:Fear; D005260:Female; D017353:Gene Deletion; D018390:Gene Targeting; D006579:Heterozygote; D006624:Hippocampus / Q000166:cytology*; D006720:Homozygote; D007150:Immunohistochemistry; D008297:Male; D008568:Memory / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D008869:Microtubule-Associated Proteins / Q000235:genetics* / Q000378:metabolism; D009043:Motor Activity; D009474:Neurons / Q000166:cytology / Q000502:physiology*; D017239:Paclitaxel / Q000494:pharmacology; D010446:Peptide Fragments; D010759:Phosphorus Isotopes; D010766:Phosphorylation; D012333:RNA, Messenger / Q000096:biosynthesis; D011930:Reaction Time; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013234:Stem Cells; D014404:Tubulin / Q000378:metabolism
D020533:Angiogenesis Inhibitors; D008869:Microtubule-Associated Proteins; D010446:Peptide Fragments; D010759:Phosphorus Isotopes; D012333:RNA, Messenger; D014404:Tubulin; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D017239:Paclitaxel